Locations:
Search IconSearch

Enhanced Level of Care Before and After Transplantation Critical for Transplant Success

Cleveland Clinic maintains post-transplant hospital stay and readmission rates below national average

650×450-Wee

A 38-year-old patient presented to Cleveland Clinic Glickman Urological & Kidney Institute’s Kidney Transplant Program having previously undergone a living donor kidney transplant at a different medical center. The transplanted kidney failed five years after the initial procedure and she was denied a second procedure at that institution.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Since she already experienced one rejection, we knew that the case was immunologically challenging,” says Alvin Wee, MD, Surgical Director for the program. “But we still believed we could help her.”

In the conversation below, Dr. Wee explains how the intense level of care provided by his team contributes to transplant success, despite medical challenges transplant patients face.

How are patients prepared for transplantation here?

Dr. Wee: Patients are first educated about the entire procedure, so that they can clearly understand our expectations ― regarding compliance, such as follow-up after surgery, medications and support ― and what they can expect. This is very important since no matter how good the surgical and medical teams are, if the patient does not cooperate, the procedure can fail. The patient needs to understand early on that transplantation is a joint effort and joint responsibility.

What is the program’s “philosophy”?

Dr. Wee: First, we treat the patient as a whole and take into consideration his or her individual situation and all medical issues. Second, we get to know patients before their transplant. And after transplantation, we see them twice a week for the first month. Contrary to the general perception, patients really appreciate this enhanced level of care and do not find it inconvenient.

Why is intense follow-up so important?

Dr. Wee: When a patient is on dialysis for a prolonged period and then is transplanted, the body needs to abruptly adapt to shifting of volumes and electrolyte changes. Most of these changes occur within the first 30 days. Intense communication and interaction are very important. In the post-transplant period, patients typically have many questions and frequent visits provide an opportunity to get them answered, and problems or concerns are identified very early. Regular follow-up during the first year ensures continuity of care.

Advertisement

Does this enhanced level of care help explain your better-than-average length of stay and readmission rates?

Dr. Wee: Yes, both our length of hospital stay and readmission rates are below the national average. For living donor transplantations, the national average hospital stay is five days while at Cleveland Clinic it is three days. For deceased donor transplantations, the national average hospital stay is seven days, and at Cleveland Clinic it is four days. In terms of readmission rates, the national average is approximately 30 percent and at Cleveland Clinic it is 14 percent. These low numbers reflect the enhanced level of care provided to our patients before and after transplantation.

Back to the patient you mentioned earlier. What was her outcome?

Dr. Wee: We took the time to explain the process of receiving a kidney transplantation from a deceased donor to both her and her family, emphasizing that her cooperation was critical for success of the entire procedure. She was discharged after spending only three days in the hospital. Her post-operative journey was uneventful. Patient is very happy and satisfied with the care she received and with her outcome.

Advertisement

Related Articles

young pain with scrotal pain
December 26, 2025/Urology & Nephrology/Urology
Efficiency Matters When Managing Testicular Torsion

Pediatric urologists lead quality improvement initiative, author systemwide guideline

Dr. Thomas with a patient
Evolving Paradigms in Hypertension Management

Fixed-dose single-pill combinations and future therapies

Dr. Lundy counseling a patient in clinic
November 25, 2025/Urology & Nephrology
Clinical Pearls for Treating Infertility and Low Testosterone in Men

Reproductive urologists publish a contemporary review to guide practice

Dr. Hoang Roberts in the operating room
November 20, 2025/Urology & Nephrology/Urology
Utilizing the Single-Port Robot for Sacrocolpopexy and Hysterectomy To Empower Patients

Two recent cases show favorable pain and cosmesis outcomes

Person shaking pills into their hands
September 26, 2025/Urology & Nephrology/Nephrology
IgA Nephropathy: Reviewing the Evidence on Current and Future Therapies

Proteinuria reduction remains the most important treatment target.

Pathology slide of IgA
September 25, 2025/Urology & Nephrology/Nephrology
IgA Nephropathy: Reviewing the Evidence on Pathogenesis, Diagnosis and Prognosis

IgA nephropathy is a relatively common autoimmune glomerular disease that can be diagnosed only by biopsy

Dr. Almassi in the operating room
Nerve-Sparing Cystectomy Preserves Sexual Function in Men With Bladder Cancer

Oncologic and functional outcomes are promising, but selection is key

Ad